AI & Machine Learning

A new health initiative aims to fight chronic disease with personalized nutrition. But can data from your body truly fix a broken food system?

Lucid crushed its 2025 production goals with a huge Q4 surge, but a widening gap between cars built and sold raises serious questions about demand.

At CES 2026, Ubicept's new toolkit promises to let AI see clearly in the dark and at high speed, ushering in a new era for robotics and autonomous cars.

BridGene Biosciences adds Nobel winner Dr. Bruce Beutler to its board, gaining immense credibility for its mission to create drugs for intractable diseases.

A new initiative is tackling the fear and distrust that costs patients their health and the system trillions. Is 'cognitive safety' healthcare's next frontier?

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

Fintech firm Movemint's rebrand signals a major shift for banks, focusing on embedded finance and personalized experiences to drive measurable growth.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

William Healey, a 25-year veteran, takes the helm as IAAO's 2026 President, guiding the future of global property valuation amid technological change.

With a $257M war chest and a veteran team, BlossomHill will showcase its innovative pipeline for lung cancer and leukemia at the pivotal JPM conference.

AUKEY unveils a 200W GaN charging hub with retractable cables and 25W Qi2, leading a new lineup designed to declutter the modern professional's desk.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.

A new partnership aims to accelerate driver safety tech in next-gen vehicles, merging AI monitoring with a fortress-like operating system.

With 35 years at the company, new CEO John Baylouny plans to accelerate R&D and expand into new markets, building on a period of strong growth.

QuinStreet's major acquisition of HomeBuddy aims to reshape the digital home services market by combining scale with exclusive, high-intent contractor leads.

Routeware appoints proven tech leaders Jeremy Collins and Ray Greer to drive its next growth phase, focusing on platform modernization and market leadership.

Dnsys scores three CES 2026 Innovation Awards for its Z1 exoskeleton, merging advanced human augmentation with gaming culture for the consumer market.

A new solution promises to bridge the gap between social media ads and retail sales, turning fuzzy awareness campaigns into measurable performance drivers.

A new partnership between etherWhere and AsiaRF promises ultra-low power, high-precision location tracking for everything from police cameras to Wi-Fi 7.

A tiny implant stimulating the vagus nerve offers new hope for severe RA. A landmark study now validates this bioelectric therapy for patients out of options.